Peptide Schedule

Not medical advice. Talk to your provider before using any peptide.

Full disclaimer
Dave Asprey
Founder, BulletproofCEO, Upgrade LabsBestselling Author

Dave Asprey

Biohacker & Bulletproof Founder

biohackinglongevityanti agingperformance

Built Bulletproof Coffee into a household name, then pivoted to longevity science with Upgrade Labs and a 500K+ YouTube following. Dave Asprey calls epithalon "the most understated peptide in our toolbox" and BPC-157 "probably my favorite peptide next to epitalon." Those quotes come from podcast episodes, not published protocols; zero specific dosing exists in any public source. His audience reach is large. His peptide data is not.

0 protocols·2 peptides·3 sources
Epitalon is the most understated peptide in our toolbox.

Dave Asprey

Dave Asprey built Bulletproof Coffee, founded Upgrade Labs, and has a 500K+ YouTube following built on biohacking content. He calls epithalon "the most understated peptide in our toolbox" and BPC-157 "probably my favorite peptide next to epitalon." Both quotes come from podcast episodes, not published articles with dosing tables.

That gap between enthusiasm and data is the story here. Asprey has a financial relationship with BioLongevity Labs and regularly discusses peptides on The Human Upgrade podcast. He follows something like the Khavinson protocol for epithalon (inferred from context, not confirmed with exact numbers). Specific milligram doses for any peptide remain locked in podcast audio or unpublished.

No protocols are tracked on this page because no verifiable dosing exists. Asprey's contribution is audience reach and awareness. If you arrived here searching for his peptide stack, the verified protocols from Greenfield and Campbell cover the same compounds with published dosing.

Protocols by Dave

0 disclosed protocols with verified dosing details.

No protocols have been added for Dave Asprey yet. Check back after our research is complete.

Source Timeline

Verified sources where Dave discussed peptide protocols.

PodcastJan 2025

Calls BPC-157 favorite peptide; no dosing

PodcastJun 2024

Mentions epithalon use, Khavinson protocol context

PodcastMar 2020

Discusses epithalon and BPC-157; no specific dosing

Protocols shown here are based on publicly disclosed information from Dave Asprey. They are reproduced for educational purposes only and are not endorsements. Always consult a healthcare provider before starting any peptide protocol.